Editorial · 2012
EditorialPublished 2017
Can PCI Ever Replace Optimal Medical Therapy in Treating“ Stable” Epicardial Coronary Stenosis?
Similar by topic
Article · 27 May 2026
Commentary on Stent-Induced Coronary Stenosis in a Previously Noncritical Segment Following PCI: A Case Report
Conference abstract · 16 Sep 2024
A clinical study of serum GGT, Cyr61 combined FFR values to predict the risk of major adverse cardiac events in patients with moderate coronary artery stenosis after PCI
Conference abstract · 13 Aug 2024
Clinical study of platelet volume and neutrophil to lymphocyte ratio predicting the risk of major cardiac adverse events in patients with moderate coronary artery stenosis after PCI
Commentary · 30 Mar 2022
A Brief Note on Percutaneous Coronary Intervention (PCI) and Procedure for the Treatment of Coronary Artery Stenosi
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Advances in Antiplatelet Therapy for Secondary Prevention of Myocardial Infarction
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Cheuk-Kit Wong”

